Health
Start-up receives NIH grant to accelerate development of contrast agent to detect liver fibrosis – News-Medical.Net
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Instit…
Reviewed by Emily Henderson, B.Sc.Oct 15 2020
Inlighta Biosciences, LLC, a start-up company led by Jenny Yang, Regents’ Professor of Chemistry at Georgia State University, has been awarded a National Institute of Health grant to accelerate development of a magnetic resonance imaging contrast agent to detect liver fibrosis, formation of scar tissue in the liver caused by alcoholic and non-alcoholic fatty liver disease.
We have been working on this breakthrough in the lab for several years. This…
-
General24 hours agoDonald Trump and the ghost of Al Capone • Inside Story
-
Noosa News23 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Noosa News8 hours agoExcellence awards nominations received – Proctor
-
Noosa News12 hours agoThe postcodes where rent chews up half your pay cheque